Verizon adds calling to more countries in Latin America, including Cuba, at no additional cost
Staying in touch with loved ones has never been easier or more affordable with Global…
News
First-Ever Crypto Polo Cup Takes South Florida by Storm
Palm Beach, Florida–(Newsfile Corp. – April 13, 2022) – The first-ever Crypto Polo Cup to…
Cylix Data Corporation Provides Innovative Resource for Fraud Mitigation
Xigem’s Business Intelligence Unit Helps Clients Detect and Avoid Fraud Toronto, Ontario–(Newsfile Corp. – April…
Top Data and Analytics Players from ASEAN to Assemble for the 3rd Global Edition of World Data & Analytics Show
Singapore, Apr 13, 2022 – (ACN Newswire) – The 3rd global edition of World Data…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Playstudios, Inc. (MYPS) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
KBRA Assigns Preliminary Ratings to Morgan Stanley Residential Mortgage Loan Trust 2022-INV1 (MSRM 2022-INV1)
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to 26 classes of mortgage pass-through certificates from Morgan…
KBRA Assigns Preliminary Ratings to Logan CLO III, Ltd.
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to three classes of notes issued by Logan CLO…
Cross River Supports American Veterans Through Partnership with Heroes to Heroes Program
FORT LEE, N.J.–(BUSINESS WIRE)–Cross River Bank (“Cross River”), a technology infrastructure provider that offers embedded…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Amazon.com, Inc. (AMZN) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Optii Solutions, The Leading Cloud-Based Hotel Operations Software, Continues its Expansion With the Appointment of Dino Pietropaolo as Chief Technology Officer
AUSTIN, Texas–(BUSINESS WIRE)–Optii Solutions, the leading cloud-based hotel operations software, today announced the appointment of…
Inergy Launches First and Only EMP-Proof Solar Generator
Inergy and EMP Shield Collaborate to Bring New EMP Protection to Portable Solar Power Storage…
C3 AI on The Financial Times’ List of Fastest Growing Companies
REDWOOD CITY, Calif.–(BUSINESS WIRE)–C3 AI (NYSE: AI), the Enterprise AI software company, has been named…
KBRA Assigns Preliminary Ratings to ACM Auto Trust 2022-1
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to four classes of notes issued by ACM Auto…
Piper Sandler Hires Robyn Moore to Lead Colorado Governmental Public Finance Business
MINNEAPOLIS–(BUSINESS WIRE)–Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the…
Foghorn Therapeutics Presents New Preclinical Data on Novel BRG1/BRM Inhibitor FHD-286 at the 2022 AACR Annual Meeting
CAMBRIDGE, Mass., April 13, 2022 (GLOBE NEWSWIRE) — Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a company…
New data show HOOKIPA’s arenaviral immunotherapies induce potent T cell responses in novel combinations and against tumor self-antigens
Preclinical data on combination with co-stimulatory 4-1BB agonists or adoptive T cell transfer showed potent…
Portage Biotech Highlights Promising Data Presented on STING-Activating Therapy, PORT-5 (STI-001) at AACR 2022 Annual Meeting
Late-breaking preclinical data generated by Stimunity suggests that packaging cGAMP STING activator in a virus-like…
Biofrontera Inc. Announces FDA Approval of Biofrontera Pharma GmbH as a Contract Laboratory for Ameluz®
Significantly Improves Manufacturing Efficiency, Quality Control and Supply Reliability WOBURN, Mass., April 13, 2022 (GLOBE…
Mustang Bio Announces a Phase 1 Clinical Trial Combining MB-101 (IL13Rα2‐targeted CAR T cell therapy) and MB-108 (C134 oncolytic virus) for the Treatment of Glioblastoma
MB‐101 (IL13Rα2‐targeted CAR T cell therapy) and MB-108 (C134 oncolytic virus) are well tolerated in…